
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Alembic Pharmaceuticals' shares surged over 4% after receiving final USFDA approval for its generic Dapagliflozin tablets, a key drug for type 2 diabetes.
Alembic Pharmaceuticals receives final USFDA approval for Dapagliflozin tablets, a key diabetes drug, triggering a 4% stock surge and securing 180 days of shared exclusivity.
Analysts offer mixed ratings on Alkem Laboratories, with price targets varying widely amidst recent earnings reports and future growth prospects for the pharmaceutical company.
Alembic Pharmaceuticals' shares surged by over 4% after receiving final USFDA approval for its generic Dapagliflozin tablets, a key drug for type 2 diabetes.
An in-depth look at Birlasoft's recent financial performance, the impact of its Q3 results, and revised price targets from major brokerages like Nomura and HDFC Securities.
Lodha Developers reported a 16% rise in FY26 pre-sales to ₹20,530 crore but missed its annual guidance due to sales deferrals caused by geopolitical conflict in West Asia.
Indian equity markets surged as positive global cues, rate cut hopes, and optimism over a US-India trade deal boosted investor sentiment.
Indian markets saw a minor dip with Sensex and Nifty closing lower, but a strong rally in IT and defensive stocks cushioned the fall amid clear sector rotation.
Indian railway stocks like RVNL and IRFC rallied up to 13% following a passenger fare hike and strong expectations for increased capital expenditure in the upcoming Union Budget.
Samsung Electronics projects a record-breaking first-quarter operating profit of ₩57.2 trillion, driven by surging demand for AI memory chips and subsequent price hikes.
The RBI's Monetary Policy Committee is expected to hold the repo rate at 5.25% in its April 2026 meeting due to rising inflation risks from global geopolitical tensions.
Delta Corp's stock faces significant pressure, hitting a 52-week low after reporting a steep 60% drop in Q3 net profit and a 15.8% revenue decline.
JPMorgan upgrades Hindalco and Vedanta to 'overweight', citing higher aluminium prices and geopolitical tensions, projecting up to 22% potential upside for the metal stocks.
Technical analysis of the Nifty 50 suggests a market shift to a 'sell-on-rise' strategy as the index tests crucial support levels amid weakening momentum.
The Nifty Metal index rallied nearly 3%, driven by strong global prices and brokerage upgrades for key players like Hindalco, Vedanta, and Tata Steel.
Lodha Developers reports its highest-ever quarterly pre-sales of ₹58.9 billion for Q4 FY26, driven by sustained demand and improved collections, while reducing net debt.